Dr. Sheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5255 Loughboro Road Northwest
Washington, DC 20016Phone+1 202-660-6500Fax+1 202-660-6501
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019
Temple University HospitalResidency, Internal Medicine, 2013 - 2016
Rutgers New Jersey Medical SchoolClass of 2013
Certifications & Licensure
VA State Medical License 2023 - 2026
MD State Medical License 2016 - 2025
DC State Medical License 2022 - 2024
PA State Medical License 2013 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- NCCN Young Investigator Award National Comprehensive Cancer Network, 2020
- Inaugural Evelyn Lauder Young Investigator Award Breast Cancer Research Foundation and Conquer Cancer Foundation, 2019
Clinical Trials
- Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study Start of enrollment: 2021 Feb 08
Publications & Presentations
PubMed
- 3 citationsFactors associated with weight gain in pre- and post-menopausal women receiving adjuvant endocrine therapy for breast cancer.Anna-Carson Rimer Uhelski, Amanda L Blackford, Jennifer Y Sheng, Claire Snyder, Jennifer Lehman
Journal of Cancer Survivorship. 2024-10-01 - 1 citationsExploring the links of skeletal muscle mitochondrial oxidative capacity, physical functionality, and mental well-being of cancer survivors.Stephen G Gonsalves, Leorey N Saligan, Christopher M Bergeron, Philip R Lee, Kenneth W Fishbein
Scientific Reports. 2024-02-01 - The challenge of weight gain in hormone receptor-positive breast cancer.Terrence C Tsou, Avonne Connor, Jennifer Y Sheng
Oncoscience. 2024-01-01
Press Mentions
Unique Considerations for Patients with Early-Onset Breast CancerDecember 18th, 2024- Behind the Study: Weight Loss Strategies for Breast Cancer SurvivorsMarch 3rd, 2022
- LG Chem Life Sciences and TransThera Biosciences Announce FDA Clearance of IND for TT-01025, a SSAO/VAP-1 InhibitorDecember 1st, 2020
- Join now to see all
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
